These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 8980123)
1. A model for Batten disease protein CLN3: functional implications from homology and mutations. Janes RW; Munroe PB; Mitchison HM; Gardiner RM; Mole SE; Wallace BA FEBS Lett; 1996 Dec; 399(1-2):75-7. PubMed ID: 8980123 [TBL] [Abstract][Full Text] [Related]
2. Batten disease: evaluation of CLN3 mutations on protein localization and function. Haskell RE; Carr CJ; Pearce DA; Bennett MJ; Davidson BL Hum Mol Genet; 2000 Mar; 9(5):735-44. PubMed ID: 10749980 [TBL] [Abstract][Full Text] [Related]
3. The subcellular location of the yeast Saccharomyces cerevisiae homologue of the protein defective in the juvenile form of Batten disease. Croopnick JB; Choi HC; Mueller DM Biochem Biophys Res Commun; 1998 Sep; 250(2):335-41. PubMed ID: 9753630 [TBL] [Abstract][Full Text] [Related]
4. Investigation of Batten disease with the yeast Saccharomyces cerevisiae. Pearce DA; Sherman F Mol Genet Metab; 1999 Apr; 66(4):314-9. PubMed ID: 10191120 [TBL] [Abstract][Full Text] [Related]
5. Cross-species homology of the CLN3 gene. Taschner PE; de Vos N; Breuning MH Neuropediatrics; 1997 Feb; 28(1):18-20. PubMed ID: 9151313 [TBL] [Abstract][Full Text] [Related]
6. Strategy for mutation detection in CLN3: characterisation of two Finnish mutations. Munroe PB; O'Rawe AM; Mitchison HM; Järvelä IE; Santavuori P; Lerner TJ; Taschner PE; Gardiner RM; Mole SE Neuropediatrics; 1997 Feb; 28(1):15-7. PubMed ID: 9151312 [TBL] [Abstract][Full Text] [Related]
7. A yeast model for the study of Batten disease. Pearce DA; Sherman F Proc Natl Acad Sci U S A; 1998 Jun; 95(12):6915-8. PubMed ID: 9618513 [TBL] [Abstract][Full Text] [Related]
9. Structure of the CLN3 gene and predicted structure, location and function of CLN3 protein. Mitchison HM; Taschner PE; Kremmidiotis G; Callen DF; Doggett NA; Lerner TJ; Janes RB; Wallace BA; Munroe PB; O'Rawe AM; Gardiner RM; Mole SE Neuropediatrics; 1997 Feb; 28(1):12-4. PubMed ID: 9151311 [TBL] [Abstract][Full Text] [Related]
10. A disrupted homologue of the human CLN3 or juvenile neuronal ceroid lipofuscinosis gene in Saccharomyces cerevisiae: a model to study Batten disease. Guo WX; Mao C; Obeid LM; Boustany RM Cell Mol Neurobiol; 1999 Oct; 19(5):671-80. PubMed ID: 10384264 [TBL] [Abstract][Full Text] [Related]
13. Absence of Btn1p in the yeast model for juvenile Batten disease may cause arginine to become toxic to yeast cells. Vitiello SP; Wolfe DM; Pearce DA Hum Mol Genet; 2007 May; 16(9):1007-16. PubMed ID: 17341489 [TBL] [Abstract][Full Text] [Related]
14. A role in vacuolar arginine transport for yeast Btn1p and for human CLN3, the protein defective in Batten disease. Kim Y; Ramirez-Montealegre D; Pearce DA Proc Natl Acad Sci U S A; 2003 Dec; 100(26):15458-62. PubMed ID: 14660799 [TBL] [Abstract][Full Text] [Related]
15. A novel c.1135_1138delCTGT mutation in CLN3 leads to juvenile neuronal ceroid lipofuscinosis. Drack AV; Miller JN; Pearce DA J Child Neurol; 2013 Sep; 28(9):1112-6. PubMed ID: 23877479 [TBL] [Abstract][Full Text] [Related]
17. Defective lysosomal arginine transport in juvenile Batten disease. Ramirez-Montealegre D; Pearce DA Hum Mol Genet; 2005 Dec; 14(23):3759-73. PubMed ID: 16251196 [TBL] [Abstract][Full Text] [Related]
18. btn1, the Schizosaccharomyces pombe homologue of the human Batten disease gene CLN3, regulates vacuole homeostasis. Gachet Y; Codlin S; Hyams JS; Mole SE J Cell Sci; 2005 Dec; 118(Pt 23):5525-36. PubMed ID: 16291725 [TBL] [Abstract][Full Text] [Related]
19. Action of BTN1, the yeast orthologue of the gene mutated in Batten disease. Pearce DA; Ferea T; Nosel SA; Das B; Sherman F Nat Genet; 1999 May; 22(1):55-8. PubMed ID: 10319861 [TBL] [Abstract][Full Text] [Related]
20. Experimental models of NCL: the yeast model. Pearce DA Adv Genet; 2001; 45():205-16. PubMed ID: 11332774 [No Abstract] [Full Text] [Related] [Next] [New Search]